Developments FDA approves launch of clinical study for Envoy’s breakthrough implanted hearing device Envoy Medical (NASDAQ:COCH) has announced that the FDA has approved its Investigational Device Exemption application for the pivotal study of its Acclaim fully implanted cochlear implant. The company asserts that the... November 1, 2024